Comprehensive Evaluation of <scp>YJ</scp> ‐2 as a <scp>PAD4</scp> Inhibitor in Alleviating Ischemic Brain Injury: From <scp>NETs</scp> ‐Induced Neurotoxicity to In Vivo Neuroprotection

Yijiang Jia, Ayijiang Taledaohan, Kai Wang, Maer Maer Tuohan, Rong Chen, Liujia Chan, Haoyu Shen, Di Zhu, Yuji Wang

Open source

DOI
10.1002/cns.71032
Published
2026-07
Container
CNS Neuroscience &amp; Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cns.71032,
  title = {Comprehensive Evaluation of
                    <scp>YJ</scp>
                    ‐2 as a
                    <scp>PAD4</scp>
                    Inhibitor in Alleviating Ischemic Brain Injury: From
                    <scp>NETs</scp>
                    ‐Induced Neurotoxicity to In Vivo Neuroprotection},
  author = {Yijiang Jia and Ayijiang Taledaohan and Kai Wang and Maer Maer Tuohan and Rong Chen and Liujia Chan and Haoyu Shen and Di Zhu and Yuji Wang},
  year = {2026},
  journal = {CNS Neuroscience \&amp; Therapeutics},
  doi = {10.1002/cns.71032},
  url = {https://doi.org/10.1002/cns.71032}
}

RIS

TY  - JOUR
TI  - Comprehensive Evaluation of
                    <scp>YJ</scp>
                    ‐2 as a
                    <scp>PAD4</scp>
                    Inhibitor in Alleviating Ischemic Brain Injury: From
                    <scp>NETs</scp>
                    ‐Induced Neurotoxicity to In Vivo Neuroprotection
AU  - Yijiang Jia
AU  - Ayijiang Taledaohan
AU  - Kai Wang
AU  - Maer Maer Tuohan
AU  - Rong Chen
AU  - Liujia Chan
AU  - Haoyu Shen
AU  - Di Zhu
AU  - Yuji Wang
PY  - 2026
JO  - CNS Neuroscience &amp; Therapeutics
DO  - 10.1002/cns.71032
UR  - https://doi.org/10.1002/cns.71032
ER  - 

APA

Jia, Y., Taledaohan, A., Wang, K., Tuohan, M. M., Chen, R., Chan, L., Shen, H., Zhu, D., & Wang, Y. (2026). Comprehensive Evaluation of <scp>YJ</scp> ‐2 as a <scp>PAD4</scp> Inhibitor in Alleviating Ischemic Brain Injury: From <scp>NETs</scp> ‐Induced Neurotoxicity to In Vivo Neuroprotection. CNS Neuroscience &amp; Therapeutics. https://doi.org/10.1002/cns.71032

Source records